Latigo Biotherapeutics

Develops non-opioid small molecule medicines for chronic pain relief.

Discussion
BiotechnologyPharmaceuticals latigobio.com ↗

Company facts

Founded
2020
Employees
50
Headquarters
United States
Type
Private
Funding
Series B · $150M · 2025